Gopinath, Shilpa
Sutaria, Nishadh
Bordeaux, Zachary A.
Parthasarathy, Varsha
Deng, Junwen
Taylor, Matthew T.
Marani, Melika
Lee, Kevin
Pritchard, Thomas
Alajmi, Ali
Adawi, Waleed
Oladipo, Olusola O.
Semenov, Yevgeniy R.
Alphonse, Martin
Kwatra, Shawn G. https://orcid.org/0000-0003-3736-1515
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR077073)
Article History
Received: 16 October 2021
Revised: 29 March 2022
Accepted: 19 April 2022
First Online: 10 May 2022
Declarations
:
: Dr. Kwatra is an advisory board member/consultant for Abbvie, Celldex Therapeutics, Galderma, Incyte Corporation, Novartis, Pfizer, Regeneron, Sanofi, and Kiniksa Pharmaceuticals and has served as an investigator for Galderma, Kiniksa Pharmaceuticals, Pfizer Inc., and Sanofi. The other authors have no conflict of interest to declare.
: This article does not contain any studies with human participants or animals performed by any of the authors.